Skip to search formSkip to main contentSkip to account menu

0.05 ML aflibercept 40 MG/ML Injection

Known as: AFLIBERCEPT 2MG/0.05ML INJ,OPH, aflibercept 2 MG per 0.05 ML Intravitreal Injection, AFLIBERCEPT 2MG/0.05ML INJ,OPH [VA Product] 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (1)

0.05 ML aflibercept 40 MG/ML Injection [Eylea]
Injectionaflibercept

Broader (1)

OPHTHALMICS,OTHER

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Non-neovascular subretinal fluid secondary to choroidal osteoma controlled with intravitreal aflibercept – A case report
The aim of the study was to describe a case of subretinal fluid without neovascularization due to choroidal osteoma that was… 
2019
2019
İNTRAVİTREAL ENJEKSİYON HASTALARINDA BLEFAROSTA TİPİNİN GÖZİÇİ BASINCINA ETKİSİ
OZET Amac: Intravitreal enjeksiyon yapilan hastalarda kullanilan blefarosta (goz spekulumu) tipinin goz ici basincina etkisinin… 
2018
2018
Three-year Outcomes of a Treat-and-Extend Regimen of Intravitreal Aflibercept for Wet ARMD at the Western Eye Hospital
Wet age-related macular degeneration wARMD is the leading cause of central visual loss in elderly patients in the developed… 
2018
2018
Effect of Intravitreal Aflibercept on Optical Coherence Tomography Angiography Vessel Density in Subjects with Proliferative Diabetic Retinopathy
2016
2016
Intravitreal aflibercept for rubeosis iridis secondary to proliferative diabetic retinopathy.
The purpose of this article is to report a case with rubeosis iridis treated by intravitreal aflibercept. A 61-year-old man had… 
2015
2015
Intravitreal aflibercept effective in radiation retinopathy
Like bevacizumab and ranibizumab, aflibercept has been shown to be effective in treating radiation retinopathy. In a study… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)